Tianjin chosen for China nanotech cancer diagnostics research centre:
This article was originally published in Clinica
Executive Summary
China has launched a research centre specialising in developing nanotech solutions for cancer diagnosis and treatment. The Tianjin-based centre is a joint venture between the Chinese Academy of Sciences, the Institute of High Energy Physics, the National Center for Nanoscience & Technology and the Tianjin Medical University Cancer Institute and Hospital. It will provide an interdisciplinary research platform, for those working on developing nanotech in the field of oncology, according to the Asia-Pacific life sciences business magazine BioSpectrum.